Key words : antibiotic, azelaic acid, benzoyl peroxide, clindamycin, compliance, erythromycin, irritancy, metronidazole
Le texte complet de cet article est disponible en PDF.
| The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories LP.
| Disclosures: Dr Feldman is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, and Bristol Myers Squibb. Dr Feldman has received grants from Galderma, Astellas, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, Coria/Valeant, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel/GlaxoSmithKline, Novartis, Medicis, Leo, HanAll Pharmaceuticals, Celgene, Basilea, and Anacor and has received stock options from Photomedex. Mr Bartlett and Mr Davis have no conflicts of interest to declare.